RecruitingNot ApplicableNCT05992363
Tandem Polyurethane Stents Compared to Single Silicone Stent for Malignant Ureteral Obstruction
Sponsor
Rabin Medical Center
Enrollment
106 participants
Start Date
Dec 20, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
Malignant ureteral obstruction (MUO) is an extrinsic ureteral obstruction caused by malignant diseases. This study aim to compare tandem 6 Fr Percuflex™ stents and single large-caliber 8Fr silicone stent in patients with MUO. The primary endpoint is stent failure rate. The secondary endpoints are patient comfort, quality of life and overall survival.
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- patient with malignant ureteral obstruction
Exclusion Criteria2
- ureteral obstruction of other causes
- Language comprehension or other limitation in giving informed consent
Interventions
DEVICEureteral stent\s insertion
ureteral stent\\s insertion in the operating room
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05992363
Related Trials
Pilot Study Dara-CyBorD in Newly Diagnosed Multiple Myeloma Patients With Renal Failure
NCT061423961 location
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
NCT0600182728 locations
Target-specific immunoPET Imaging of Digestive System Carcinoma
NCT067158391 location
DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusion-Positive Cancers.
NCT0577054427 locations
DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition
NCT0577010227 locations